VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn’s
In a first direct comparison study, ustekinumab (Stelara, Janssen) emerged superior to vedolizumab (...
Discovery of ‘Achilles heel’ in gut bacteria may lead to targeted therapies for Crohn’s disease
The discovery of an “Achilles heel” in...
